1. Call for independent scientific experts to join PRAC

   News item 29 July 2017 Pages: 1 - 1

2. Dosing errors with low-dose methotrexate: TGA statement

   News item 29 July 2017 Pages: 2 - 2

3. EMA seeks public views on valproate safety review

   News item 29 July 2017 Pages: 3 - 3

4. Labelling for ibrutinib updated for risk of HBV reactivation

   Correspondence 29 July 2017 Pages: 4 - 4

5. New Q4 2016 data presented in ISMP's Annual Report

   News item 29 July 2017 Pages: 5 - 5

6. Carfilzomib better tolerated; approved for multiple melanoma

   News item 29 July 2017 Pages: 6 - 6

7. Association between exposure to antidepressants and autism

   Clinical study 29 July 2017 Pages: 7 - 7

8. Congenital malformations following fluoxetine exposure

   Clinical study 29 July 2017 Pages: 8 - 8

9. Intellectual disability following in utero antidepressant exposure

   Clinical study 29 July 2017 Pages: 9 - 9

10. Prescribing error rates reduced by pharmacist feedback

    Clinical study 29 July 2017 Pages: 10 - 10

11. Vancomycin nephrotoxicity increased in obese patients

    Clinical study 29 July 2017 Pages: 11 - 11

12. Views of primary care physicians on deprescribing

    Clinical study 29 July 2017 Pages: 12 - 12

13. Antineoplastics

    Case report 29 July 2017 Pages: 13 - 13

14. Aciclovir

    Case report 29 July 2017 Pages: 14 - 14

15. Aciclovir overdose

    Case report 29 July 2017 Pages: 15 - 15

16. Acitretin

    Case report 29 July 2017 Pages: 16 - 16

17. Acitretin/methotrexate

    Case report 29 July 2017 Pages: 17 - 17

18. Adalimumab

    Case report 29 July 2017 Pages: 18 - 18

19. Adalimumab

    Case report 29 July 2017 Pages: 19 - 19

20. Adalimumab

    Case report 29 July 2017 Pages: 20 - 20

21. Adalimumab/etanercept

    Case report 29 July 2017 Pages: 21 - 21

22. Adenosine/atenolol

    Case report 29 July 2017 Pages: 22 - 22

23. Afatinib

    Case report 29 July 2017 Pages: 23 - 23

24. Afatinib/erlotinib

    Case report 29 July 2017 Pages: 24 - 24

25. Aflibercept

    Case report 29 July 2017 Pages: 25 - 25

26. Alemtuzumab

    Case report 29 July 2017 Pages: 26 - 26

27. Alendronic acid

    Case report 29 July 2017 Pages: 27 - 27

28. Alendronic-acid

    Case report 29 July 2017 Pages: 28 - 28

29. Alteplase

    Case report 29 July 2017 Pages: 29 - 29

30. Alteplase/dornase alfa

    Case report 29 July 2017 Pages: 30 - 30

31. Alteplase/ramipril

    Case report 29 July 2017 Pages: 31 - 31

32. Ambrisentan/sildenafil/treprostinil

    Case report 29 July 2017 Pages: 32 - 32

33. Amiodarone

    Case report 29 July 2017 Pages: 33 - 33

34. Amiodarone/mexiletine

    Case report 29 July 2017 Pages: 34 - 34

35. Amphotericin-B-liposomal

    Case report 29 July 2017 Pages: 35 - 35

36. Ampicillin

    Case report 29 July 2017 Pages: 36 - 36

37. Ampicillin/cotrimoxazole

    Case report 29 July 2017 Pages: 37 - 37

38. Anakinra/tacrolimus

    Case report 29 July 2017 Pages: 38 - 38

39. Anastrozole

    Case report 29 July 2017 Pages: 39 - 39

40. Antibiotics

    Case report 29 July 2017 Pages: 40 - 40

41. Antineoplastics

    Case report 29 July 2017 Pages: 41 - 41

42. Antineoplastics

    Case report 29 July 2017 Pages: 42 - 42

43. Antineoplastics

    Case report 29 July 2017 Pages: 43 - 43

44. Antineoplastics

    Case report 29 July 2017 Pages: 44 - 44

45. Antineoplastics

    Case report 29 July 2017 Pages: 45 - 45

46. Antineoplastics

    Case report 29 July 2017 Pages: 46 - 46

47. Antineoplastics

    Case report 29 July 2017 Pages: 47 - 47

48. Antiretrovirals

    Case report 29 July 2017 Pages: 48 - 48

49. Antiretrovirals

    Case report 29 July 2017 Pages: 49 - 49

50. Antiretrovirals

    Case report 29 July 2017 Pages: 50 - 50